P Emery Selected Research

P Emery Research Topics

Disease

86	Rheumatoid Arthritis 09/2020 - 02/2000
28	Necrosis 09/2020 - 07/2000
17	Arthritis (Polyarthritis) 10/2016 - 01/2000
14	Synovitis 12/2017 - 01/2000
14	Rheumatic Diseases (Rheumatism) 03/2016 - 12/2000
12	Inflammation (Inflammations) 12/2017 - 08/2000
11	Ankylosing Spondylitis 01/2014 - 09/2004
9	Pain (Aches) 01/2020 - 05/2003
9	Autoimmune Diseases (Autoimmune Disease) 11/2018 - 10/2000
8	Psoriatic Arthritis 03/2016 - 05/2003
7	Infections 04/2011 - 10/2003
6	Spondylarthropathies 07/2010 - 09/2001
6	Fatigue 01/2010 - 12/2004
5	Disease Progression 09/2004 - 05/2000
4	Systemic Scleroderma (Systemic Sclerosis) 07/2010 - 06/2001
4	Back Pain (Backache) 07/2010 - 09/2004
4	Osteitis 03/2010 - 09/2004
3	Injection Site Reaction 01/2018 - 05/2004
3	Exanthema (Rash) 11/2008 - 06/2000
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2004 - 01/2001
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2016 - 01/2014
2	Crohn Disease (Crohn's Disease) 04/2015 - 01/2003
2	Chronic Disease (Chronic Diseases) 12/2011 - 06/2008
2	Hypersensitivity (Allergy) 07/2011 - 06/2000
2	Sacroiliitis 07/2010 - 11/2008
2	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2010 - 04/2008
2	Tuberculosis (Tuberculoses) 06/2010 - 03/2001
2	Knee Osteoarthritis 04/2010 - 11/2007
2	Headache (Headaches) 11/2008 - 06/2000
2	Acne Vulgaris 05/2007 - 02/2001
2	Hypertension (High Blood Pressure) 01/2001 - 08/2000
2	Alopecia (Baldness) 06/2000 - 06/2000
1	Cutaneous Lupus Erythematosus 10/2019
1	Joint Diseases (Joint Disease) 01/2016
1	Vasculitis (Vasculitides) 09/2014
1	Axial Spondyloarthritis 01/2014

Drug/Important Bio-Agent (IBA)

24	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 06/2000
23	Biological ProductsIBA 01/2020 - 11/2002
19	Antirheumatic Agents (DMARD)IBA 01/2020 - 01/2000
13	Infliximab (Remicade)FDA Link 01/2014 - 11/2000
12	Rituximab (Mabthera)FDA Link 06/2015 - 12/2006
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2009 - 11/2000
9	Etanercept (Enbrel)FDA Link 01/2018 - 09/2001
8	Tumor Necrosis Factor InhibitorsIBA 03/2016 - 08/2006
8	Leflunomide (Arava)FDA LinkGeneric 11/2007 - 05/2000
7	Monoclonal AntibodiesIBA 06/2010 - 11/2000
6	Pharmaceutical PreparationsIBA 03/2010 - 01/2001
6	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2009 - 02/2000
5	ametantrone (HAQ)IBA 01/2020 - 06/2000
5	Abatacept (Orencia)FDA Link 09/2014 - 02/2007
4	tocilizumab (atlizumab)FDA Link 01/2020 - 09/2006
4	Biomarkers (Surrogate Marker)IBA 10/2016 - 06/2001
4	Proteins (Proteins, Gene)FDA Link 10/2016 - 03/2001
4	AntibodiesIBA 09/2015 - 04/2006
4	Rheumatoid FactorIBA 06/2014 - 08/2000
4	C-Reactive ProteinIBA 07/2010 - 08/2000
4	GadoliniumIBA 03/2009 - 05/2001
4	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 04/2006 - 09/2004
3	Adalimumab (Humira)FDA Link 01/2020 - 12/2003
3	Anti-Citrullinated Protein AntibodiesIBA 12/2017 - 04/2006
3	AutoantibodiesIBA 09/2014 - 10/2000
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2014 - 08/2000
3	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 07/2010 - 11/2008
3	cyclic citrullinated peptideIBA 03/2010 - 04/2006
3	CytokinesIBA 04/2008 - 06/2001
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 02/2008 - 09/2004
2	InterferonsIBA 11/2018 - 10/2018
2	ElementsIBA 12/2017 - 05/2009
2	Certolizumab Pegol FDA Link 01/2017 - 05/2015
2	Peptides (Polypeptides)IBA 09/2015 - 02/2011
2	Immunomodulating AgentsIBA 04/2015 - 04/2011
2	EpitopesIBA 06/2014 - 01/2009
2	SteroidsIBA 01/2014 - 11/2008
2	HLA-DRB1 Chains (HLA DRB1)IBA 02/2012 - 08/2000
2	VaccinesIBA 04/2011 - 03/2011
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 11/2009 - 11/2008
2	TACI receptor-IgG Fc fragment fusion proteinIBA 07/2009 - 01/2008
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 11/2008 - 09/2006
2	Minocycline (Cyclops)FDA LinkGeneric 05/2007 - 02/2001
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2006 - 01/2001
2	Methylprednisolone FDA LinkGeneric 05/2004 - 05/2001
2	AntigensIBA 03/2001 - 02/2001
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 08/2000 - 06/2000
2	EnzymesIBA 06/2000 - 06/2000
1	Biosimilar PharmaceuticalsIBA 09/2020
1	TESIBA 01/2020
1	baricitinibIBA 01/2020
1	tofacitinibIBA 01/2020
1	Interferon Type IIBA 11/2018
1	etanercept biosimilar SB4IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 12/2017
1	Adenosine Monophosphate (AMP)IBA 01/2016
1	Antimicrobial PeptidesIBA 01/2016
1	Amino Acids FDA Link 02/2012

Therapy/Procedure

43	Therapeutics 03/2016 - 01/2000
6	Biological Therapy 08/2011 - 09/2003
5	Stem Cell Transplantation 08/2004 - 12/2000
2	Remission Induction 06/2014 - 01/2014
2	Drug Tapering 01/2001 - 08/2000
1	Lasers (Laser) 10/2019